15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has declined 2.2% per year over the past 5 years.
Operating margin has expanded, at 15.8% in the latest year.
Free cash flow has declined 15.5% per year over the past 5 years.
Financial health
Total debt ($3.0B) exceeds cash ($6M); net debt is $3.0B.
Total debt has grown in line with revenue (-2.1% vs -2.2% per year).
Total debt is 6.0× EBITDA.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2025
$1.6B
-$440M
0.0%
15.8%
—
-9.1%
$66M
$3.0B
$6M
2024
$1.7B
-$64M
0.0%
10.2%
—
-0.9%
-$195M
$3.7B
$7M
2023
$1.7B
$118M
0.0%
11.9%
—
1.7%
-$99M
$3.8B
$9M
2022
$2.8B
$75M
0.0%
11.3%
—
1.2%
-$90M
$3.5B
$8M
2021
$2.1B
-$165M
0.0%
3.6%
—
-2.8%
$37M
$3.0B
$20M
2020
$1.8B
-$417M
0.0%
-13.5%
—
-7.0%
$153M
$3.4B
$21M
2019
$2.5B
$96M
0.0%
11.0%
—
1.5%
$219M
$3.4B
$29M
2018
$2.9B
-$6M
0.0%
5.8%
—
-0.1%
$195M
$3.4B
$10M
2017
$2.0B
$83M
0.0%
10.9%
—
1.2%
$73M
$3.7B
$9M
2016
—
$113M
—
—
—
2.0%
-$180M
$3.1B
$7M
2015
—
$423M
—
—
—
7.7%
-$206M
$2.9B
$11M
2014
—
$106M
—
—
—
3.3%
-$152M
$1.6B
$9M
2013
—
$86M
—
—
—
3.0%
-$205M
$1.3B
$9M
2012
—
$96M
—
—
—
4.6%
$43M
$851M
$11M
2011
—
$51M
—
—
—
3.0%
$30M
$659M
$11M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jun '26
$532M
$43M
0.0%
19.8%
—
0.8%
$154M
$3.2B
$39M
Mar '26
$447M
$7M
0.0%
17.2%
—
0.1%
$56M
$3.2B
$4M
Dec '25
$441M
$20M
0.0%
20.4%
—
0.4%
$87M
$3.0B
$6M
Sep '25
$414M
$9M
0.0%
19.0%
—
0.2%
$43M
$3.1B
$5M
Jun '25
$377M
-$406000
0.0%
17.9%
—
-0.0%
-$8M
$3.1B
$4M
Mar '25
$398M
-$469M
0.0%
5.5%
—
-9.0%
-$57M
$3.4B
$377M
Dec '24
$399M
-$49M
0.0%
3.4%
—
-0.7%
-$47M
$3.7B
$7M
Sep '24
$397M
-$17M
0.0%
12.2%
—
-0.2%
-$32M
$4.0B
$13M
Jun '24
$430M
-$9M
0.0%
11.6%
—
-0.1%
-$68M
$3.9B
$14M
Mar '24
$434M
$11M
0.0%
13.4%
—
0.2%
-$48M
$3.8B
$7M
Dec '23
$774M
$12M
0.0%
8.5%
—
0.2%
-$99M
$3.8B
$9M
Sep '23
$808M
$58M
0.0%
13.8%
—
0.8%
-$7M
$3.6B
$21M
Jun '23
$805M
$49M
0.0%
12.8%
—
0.7%
$42M
$3.5B
$12M
Mar '23
$791M
-$2M
0.0%
6.2%
—
-0.0%
-$34M
$3.5B
$18M
Dec '22
$714M
$42M
0.0%
12.8%
—
0.7%
-$39M
$3.5B
$8M
Sep '22
$721M
$3M
0.0%
10.4%
—
0.1%
-$28M
$3.4B
$6M
Jun '22
$722M
$35M
0.0%
13.4%
—
0.6%
$3M
$3.3B
$10M
Mar '22
$632M
-$5M
0.0%
8.2%
—
-0.1%
-$26M
$3.0B
$10M
Dec '21
$582M
-$68M
0.0%
-2.1%
—
-1.2%
$12M
$3.0B
$20M
Sep '21
$519M
-$21M
0.0%
6.6%
—
-0.4%
-$52M
$3.4B
$10M
Valuation over time
How the market has priced GEL against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 18.3× (Mar '23) to 12.4× (Nov '24).
The price-to-sales ratio has risen from 0.5× (Mar '23) to 1.1× (Nov '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Frequently asked questions
Is GEL growing its revenue and profit?
Over the past 5 years, GENESIS ENERGY LP's revenue has declined 2.2% per year. These are computed facts, not advice.
How much debt does GEL have?
As of FY2025, GENESIS ENERGY LP reported $3.0B of total debt against $6M of cash.
What is GEL's profit margin?
In FY2025, gross margin was —, operating margin 15.8%, and net margin -27.0%.
What is GEL's P/E ratio?
GENESIS ENERGY LP's P/E (TTM) is 22.42 as of the 2026-11-03 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the GEL stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 12.4× as of Nov '26) can differ. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.